3,385
Views
3
CrossRef citations to date
0
Altmetric
Research Article

The Ethnomedicinal Uses of Magnoliaceae from the Southeastern United States as Leads in Drug Discovery

, &
Pages 63-69 | Published online: 10 May 2011

References

  • Belousova NI, Dmitruk SE, Khan VA (1989): Essential oils in Ledum L.: antifungal properties. Khim-Farm Zh 23: 317–319.
  • Bolyard JL (1981): Medicinal Plants and Home Remedies of Appalachia. Springfield (Illinois), Charles C Thomas. Bruneton J (1999): Pharmacognosy, Phytochemistry, Medicinal
  • Plants. Paris, Lavoisier Publishing, pp. 618–636.
  • Bushnell DI (1909): The Chocktaw of Bayou Lacomb St. Tammany Parish Louisiana. Washington, Government Printing Office.
  • Castro V, Murillo R, Klaas CA, Meunier C, Gerardo M, Pahl HL (2000): Inhibition of the transcription factor NF-KB by sesquiterpene lactones from Podachaenium eminens. Planta Med 66: 591–595.
  • Chung BS, Kim YH (1986): Studies on the constituents of Acan-thopanax koreanum. Saengyak Hakhoechi 17: 62–66.
  • Clark AM, El-Feraly FS, Li W-S (1981): Antimicrobial activity of phenolic constituents of Magnolia grandiflora L. J Pharm Sci 70: 951–952.
  • Crellin JK, Philpott J (1990): Herbal Medicine Past and Present: A Reference Guide to Medicinal Plants. Durham and London, Duke University Press.
  • Cutlan AR, Bonilla LE, Simon JE, Erwin JE (2000): Intra-specific variability of feverfew: correlations between part-henolide, morphological traits and seed origin. Planta Med 66: 612–617.
  • Duncan WH, Duncan MB (1988): Trees of the Southeastern United States. Athens and London, The University of Georgia Press.
  • El-Feraly FS (1984): Melampolides from Magnolia grandiflora. Phytochemistry 23: 2372–2374.
  • El-Feraly FS, Chan Y-M (1978): Isolation and characteri-zation of the sesquiterpene lactones costunolide, parth-enolide, costunolide diepoxide, santamarine, and reynosin from Magnolia grandiflora L. J Pharm Sci 67: 347–350.
  • El-Feraly FS, Chan Y-M, Capiton GA, Doskotch RW, Fairchild EH (1979): Isolation and characterization of peroxycos-tunolide (verlotorin) and peroxyparthenolide from Magno-lia grandiflora. Carbon-13 nuclear magnetic resonance spectroscopy of costunolide and related compounds. J Org Chem 44: 3952–3955.
  • El-Feraly FS, Chan Y-M, Fairchild EH, Doskotch RW (1977): Peroxycostunolide and peroxyparthenolide: two cytotoxic germacranolide hydroperoxides from Magnolia grandi-flora. Structural revision of verlotorin and artemorin. Tet Lett 23: 1973–1976.
  • El-Feraly FS, Li W-S (1978): Phenolic constituents of Magno-lia grandiflora L. seeds. Lloydia 41: 442–449.
  • Fischer NH (1991): Sesquiterpenoid lactones. Methods in Plant Biochemistry 7: 187–211.
  • Griffith ER (1847): Medical Botany: Or Descriptions of the More Important Plants Used in Medicine, with Their History, Properties, and Mode of Administration. Philadel-phia, Lea and Blanchard, pp. 96–100.
  • Grippo AA, Hall IH, Kiyokawa H, Muraoka 0, Shen YC, Lee KH (1992): Antitumor agents. 121. The cytotoxicity of helenalin, its mono and difunctional esters, and related sesquiterpene lactones in murine and human tumor cells. Drug Des Discovery 8: 191–206.
  • Hall IH, Lee KH, Starnes CO, Sumida Y, Wu RY, Waddell TG, Cochran JW, Gerhart KG (1979): Anti-inflammatory activ-ity of sesquiterpene lactones and related compounds. J Pharm Sci 68: 537–542.
  • Hall IH, Starnes CO, Lee KH, Waddell TG (1980): Mode of action of sesquiterpene lactones as anti-inflammatory agents. J Pharm Sci 6: 537–543.
  • Hamel PB, Chiltoskey MU (1975): Cherokee Plants; Their Uses — a 400 Year History. Sylva, North Carolina, Herald Pub-lishing Company.
  • Hegnauer R (1990): Chemotaxonomie der Pflanzen. Dicotyle-donae: Magnoliaceae to Zygophyllaceae. Basel, Birkhaeuser.
  • Hehrier SP, Hofmann TG, Droge W, Schmitz ML (1999): The anti-inflammatory sesquiterpene lactone parthenolide inhibits NF-KB by targeting the licB kinase complex. J Immunol 163: 5617–5613.
  • Heptinstall S, Awang DVC (1998): Feverfew: a review of its history, its biological and medicinal properties, and the status of commercial preparations of the herb. ACS Symp Ser 691: 158–175.
  • Herrick JW (1978): Powerful medicinal plants in traditional Iroquois culture. New York State Journal of Medicine Mai: 979–987.
  • Herrick JW (1995): Iroquois Medical Botany. Syracuse, N.Y., Syracuse University Press.
  • Hocking GM (1997): A Dictionary of Natural Products. Medford, N.J., Plexus Publisher.
  • Horigome H, Homma M, Hirano T, Oka K, Tomoyuki N, Hayashi T (2001): Magnolol from Magnolia officinalis inhibits 110-hydroxysteroid dehydrogenase without in-creases of corticosterone and thymocyte apoptosis in mice. Planta Med 67: 33–37.
  • Huang C-H, Hong C-Y, Tsai S-K, Lai S-T, Weng Z-C, Chih C-L, Hsieh Y-H (2000): Intravenous pretreatment with magnolol protects myocardium against stunning. Planta Med 66: 516–520.
  • Hutchens AR (1991): Indian Herbalogy of North America. Boston and London, Shambhala.
  • Hwang D, Fischer NH, Heekyung T, Kim JK, Jong BC, Lee W (1996): Inhibition of the expression of inducible cyclooxy-genase and proinflammatory cytokines by sesquiterpene lactones in macrophages correlates with the inhibition of MAP kinases. Biochem Biophys Res Commun 226: 810–818.
  • Jacyno JM, Montemurro N, Bates AD, Cutler HG (1991): Phy-totoxic and antimicrobial properties of cyclocolorenone from Magnolia grandiflora L. J Agric Food Chem 39: 1166–1168.
  • Johnson KS (1998): Comparative detoxification of plant (Magnolia virginiana) allelochemicals by generalist and specialist saturniid silkmoths. J Chem Ecol 25: 253–269.
  • Johnson KS, Scriber MJ, Nair MG (1996): Phenylpropenoid phenolics in sweetbay magnolia as chemical determinants of host use in saturniid silkmoths (Callosamia). J Chem Ecol 22: 1955–1969.
  • Kim Y-K, Ryu SY (1999): Cytotoxic components from stem bark of Magnolia obovata. Planta Med 65: 291–292.
  • Kimura M, Hosaka K, Mitsuhashi H (1993): Preparation of lignans and their intermediates as drugs. Eur Pat Appl 18 pp.
  • Konoshima T, Koyuka M, Tokuda H, Nishino H, Iwashima A, Haruna M, Ito K, Tanabe M (1991): Studies on inhibitors of skin tumor promotion, IX. Neolignans from Magnolia officinalis. J Nat Prod 54: 816–822.
  • Larsen A, Petersson I, Svensson B (1989): Podophyllum deriv-atives (CPH 82) compared with placebo in the treatment of rheumatoid arthritis. British J Rheumatol 28: 124–127.
  • Lee K-H (1999): Novel antitumor agents from higher plants. Med Res Rev 19: 569–596.
  • Macias FA, Galindo JCG, Massanet GM (1992): Natural product models as allelochemicals. 1. Potential allelopathic activity of several sesuiterpene lactone models. Phyto-chemistry 31: 1969–1977.
  • McDaniel JC (1966): Variations in the sweet bay magnolias. Morris Arboretum Bulletin 17: 7–12.
  • Michaux MD (1805): Travels to the Westward of the Allegany Mountains in the States of the Ohio, Kentucky and Ten-nessee. London, Richard Phillips.
  • Millspaugh CF (1975): American Medicinal Plants (An Illus-trated and Descriptive Guide to Plants Indigenous to and Naturalized in the United States which are Used in Medi-cine). New York, Dover Publications, Inc.
  • Moerman DE (1998): Native American Ethnobotany. Timber Press, Oregon.
  • Morin, NR (Ed.) (1997): Flora of North America North of Mexico. Vol. 3, Magnoliophyta: Magnoliidae and Hamameliidae, New York, Oxford Universiy Press.
  • Nagashima F, Momosaki S, Watanabe Y, Takaoka S, Huneck S, Asakawa Y (1996): Sesquiterpenoids from the liverworts Bazzania trilobata and Porella canariensis. Phytochemistry 42: 1361–1366.
  • Nitao JK, Nair MG, Thorogood DL, Johnson KS, Scriber MJ (1991): Bioactive neolignans from the leaves of Magnolia virginiana. Phytochemistry 30: 2193–2195.
  • Nitao JK, Johnson KS, Scriber MJ, Muraleedharan GN (1992): Magnolia virginiana neolignan compounds as chemical barriers to swallowtail butterfly host use. J Chem Ecol 18: 1661–1671.
  • Price TD (1802): An Inaugural Dissertation on Magnolia glauca, University of Pennsylvania.
  • Rao KV (1975): Glycosides of Magnolia grandiflora. I: Isola-tion of three crystalline glycosides. Planta Med 27: 31–36.
  • Rao KV, Davis TL (1982): Constituents of Magnolia grandi-flora. I: Mono-O-methylhonokiol. Planta Med 45: 57–59.
  • Rao KV, Juneau RJ (1975): Glycosides of Magnolia. II. Struc-tural elucidation of magnolidin. Lloydia 38: 339–342.
  • Rao KV, Wu W-N (1978): Glycosides of Magnolia. III. Struc-tural elucidation of magnolenin C. Lloydia 41: 56–62.
  • Ross JJ, Arnason JT, Birnboim HC (1999): Low concentrations of the feverfew component parthenolide inhibit in vitro growth of tumor lines in a cytostatic fashion. Planta Med 65: 126–129.
  • Small JK (1933): Manual of the Southeastern Flora. New York, published by the author.
  • Song Q, Fischer NH (1999): Biologically active lignans and neolignans from Magnolia species. Revista de la Sociedad Quimica de Mexico 43: 211–218.
  • Song Q, Fronczek FR, Fischer NH (2000): Dibenzocycloocta-diene-type lignans from Magnolia pyramidata. Phyto-chemistry 55: 653–661.
  • Song Q, Gomez-Barrios ML, Fronczek FR, Vargas D, Thien LB, Fischer NH (1998): Sesquiterpenes from southern Magno-lia Virginiana. Phytochemistry 47: 221–226.
  • Speck FB (1937): Catawba medicines and curative practices. Publications of the Philadelphia Anthropological Society: 179–197.
  • Speck FG (1941): A list of plant curatives obtained from the Houma Indians of Louisiana. Primitive Man 14: 49–75.
  • Speck FG, Hassrick RB, Carpenter ES (1942): Rappahannock Herbals, Folk-Lore and Science of Cures. Proceedings of the Delaware County Institute of Science 10: 3–55.
  • Taylor LA (1940): Plants Used as Curatives by Certain South-eastern Tribes, Cambridge, Massachusetts, Botanical Museum of Harvard University.
  • Thien LB, Heimermann WH, Holman RT (1975): Floral odors and quantitative taxonomy of Magnolia and Liriodendron. Taxon 24: 557–568.
  • Treseder NG (1978): Magnolias, London, Boston, Faber and Faber.
  • Vogel VJ (1970): American Indian Medicine. Norman, Univer-sity of Oklahoma Press.
  • Wedge DE, Galindo JCG, Macias FA (2000): Fungicidal activ-ity of natural and synthetic sesquiterpene lactone analogs. Phytochemistry 53: 747–757.
  • Wiedhopf RN/I, Young M, Bianchi E, Cole JR (1973): Tumor Inhibitory Agent from Magnolia grandiflora (Magnoli-aceae) I: Parthenolide. J Pharm Sci 62: 345.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.